The impact of neoadjuvant therapy for gastroesophageal adenocarcinoma on postoperative morbidity and mortality.

about

Comparison of neoadjuvant versus a surgery first approach for gastric and esophagogastric cancer.A population-based study on incidence rates, Lauren distribution, stage distribution, treatment, and long-term outcomes for gastric adenocarcinoma in Central Norway 2001-2011.

P2860

Q30248541-4D6B9D54-8D43-419A-9A42-FE4D18A26658 Q39317047-5444184A-EAF5-4340-8A62-1AE545A6F7D6

P2860

The impact of neoadjuvant therapy for gastroesophageal adenocarcinoma on postoperative morbidity and mortality.

Item

http://www.wikidata.org/entity/Q40962026

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The impact of neoadjuvant ther ...... ative morbidity and mortality.

@en

type

Item

label

The impact of neoadjuvant ther ...... ative morbidity and mortality.

@en

prefLabel

The impact of neoadjuvant ther ...... ative morbidity and mortality.

@en

P1476

The impact of neoadjuvant ther ...... ative morbidity and mortality.

@en

P2093

David W Rattner

http://www.w3.org/2001/XMLSchema#string

Eunice L Kwak

http://www.w3.org/2001/XMLSchema#string

Eva Fuentes

http://www.w3.org/2001/XMLSchema#string

Jeffrey W Clark

http://www.w3.org/2001/XMLSchema#string

John T Mullen

http://www.w3.org/2001/XMLSchema#string

Rima Ahmad

http://www.w3.org/2001/XMLSchema#string

Theodore S Hong

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.

Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer.

Effect of neoadjuvant chemotherapy on postoperative morbidity and mortality in patients with locally advanced gastric cancer.

Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.

Morbidity and mortality of gastrectomy for cancer in Department of Veterans Affairs Medical Centers.

Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification.

P304

560-564

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.24179

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26792144

http://www.w3.org/2001/XMLSchema#string

The impact of neoadjuvant therapy for gastroesophageal adenocarcinoma on postoperative morbidity and mortality.

about

P2860

P2860

The impact of neoadjuvant therapy for gastroesophageal adenocarcinoma on postoperative morbidity and mortality.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698